A Multicenter, Open-Label Trail to Investigate the Safety and Tolerability of Intravenous SPM 927 As Replacement for Oral SPM 9217 in Subjects with Seizures with or without Secondary Generalization

Grants and Contracts Details

StatusFinished
Effective start/end date4/20/05 → 4/30/07

Funding

  • Schwarz BioSciences Inc: $52,625.00